Rethinking the science of science funding with Sam Arbesman

The funding of science is one of the most important leverage points for growth in the global economy. Yet, we’ve barely experimented with how science gets funded or tried to evolve financing models that were invented decades ago. Now, dozens of new organizations have been started to explore novel models for funding scientists to do their best work. Danny Crichton is joined by Lux Capital’s scientist-in-residence Sam Arbesman to talk about why this trend has accelerated and what all these new experimental models might mean for the future of science.